• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在溶液中直接检测肌球蛋白超松弛状态和相互作用的头部模体。

Direct detection of the myosin super-relaxed state and interacting-heads motif in solution.

机构信息

Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota, USA.

Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota, USA.

出版信息

J Biol Chem. 2021 Oct;297(4):101157. doi: 10.1016/j.jbc.2021.101157. Epub 2021 Sep 2.

DOI:10.1016/j.jbc.2021.101157
PMID:34481842
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8479475/
Abstract

The interacting-heads motif (IHM) is a structure of myosin that has been proposed to modulate cardiac output by occluding myosin molecules from undergoing the force-generating cycle. It is hypothesized to be the structural basis for the super-relaxed state (SRX), a low-ATPase kinetic state thought to be cardioprotective. The goal of the present study was to test this hypothesis by determining directly and quantitatively the fractions of myosin in the IHM and SRX under the same conditions in solution. To detect the structural IHM, we used time-resolved fluorescence resonance energy transfer to quantitate two distinct populations. One population was observed at a center distance of 2.0 nm, whereas the other was not detectable by fluorescence resonance energy transfer, implying a distance greater than 4 nm. We confirmed the IHM assignment to the 2.0-nm population by applying the same cross-linking protocol used previously to image the IHM by electron microscopy. Under the same conditions, we also measured the fraction of myosin in the SRX using stopped-flow kinetics. Our results show that the populations of SRX and IHM myosin were similar, unless treated with mavacamten, a drug that recently completed phase III clinical trials to treat hypertrophic cardiomyopathy and is proposed to act by stabilizing both the SRX and IHM. However, we found that mavacamten had a much greater effect on the SRX (55% increase) than on the IHM (4% increase). We conclude that the IHM structure is sufficient but not necessary to produce the SRX kinetic state.

摘要

相互作用的头部模体(IHM)是肌球蛋白的一种结构,它被提出通过阻止肌球蛋白分子经历力产生循环来调节心输出量。它被假设为超松弛状态(SRX)的结构基础,SRX 是一种低 ATP 酶动力学状态,被认为具有心脏保护作用。本研究的目的是通过在相同条件下直接和定量地确定溶液中 IHM 和 SRX 中的肌球蛋白分数来检验这一假设。为了检测结构 IHM,我们使用时间分辨荧光共振能量转移来定量两个不同的群体。一个群体在中心距离为 2.0nm 处观察到,而另一个群体则不能通过荧光共振能量转移检测到,这意味着距离大于 4nm。我们通过应用以前用于通过电子显微镜成像 IHM 的相同交联方案来确认 IHM 分配到 2.0nm 群体。在相同条件下,我们还使用停流动力学测量了 SRX 中的肌球蛋白分数。我们的结果表明,除非用 mavacamten 处理,否则 SRX 和 IHM 肌球蛋白的群体相似,mavacamten 是一种最近完成 III 期临床试验以治疗肥厚型心肌病的药物,被提议通过稳定 SRX 和 IHM 起作用。然而,我们发现 mavacamten 对 SRX 的影响(增加 55%)远大于对 IHM 的影响(增加 4%)。我们得出结论,IHM 结构足以产生 SRX 动力学状态,但不是必需的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d1/8479475/1c72063370ae/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d1/8479475/7811631a25de/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d1/8479475/6fa90988467f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d1/8479475/d6ff22365a90/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d1/8479475/1c72063370ae/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d1/8479475/7811631a25de/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d1/8479475/6fa90988467f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d1/8479475/d6ff22365a90/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11d1/8479475/1c72063370ae/gr4.jpg

相似文献

1
Direct detection of the myosin super-relaxed state and interacting-heads motif in solution.在溶液中直接检测肌球蛋白超松弛状态和相互作用的头部模体。
J Biol Chem. 2021 Oct;297(4):101157. doi: 10.1016/j.jbc.2021.101157. Epub 2021 Sep 2.
2
Two Classes of Myosin Inhibitors, Para-nitroblebbistatin and Mavacamten, Stabilize β-Cardiac Myosin in Different Structural and Functional States.两类肌球蛋白抑制剂,对硝基苯并脒和 mavacamten,稳定β-心脏肌球蛋白处于不同的结构和功能状态。
J Mol Biol. 2021 Nov 19;433(23):167295. doi: 10.1016/j.jmb.2021.167295. Epub 2021 Oct 8.
3
Synthetic thick filaments: A new avenue for better understanding the myosin super-relaxed state in healthy, diseased, and mavacamten-treated cardiac systems.合成粗肌丝:深入理解健康、疾病和 mavacamten 治疗心脏系统中心肌球蛋白超级松弛状态的新途径。
J Biol Chem. 2021 Jan-Jun;296:100114. doi: 10.1074/jbc.RA120.016506. Epub 2020 Dec 3.
4
Dilated cardiomyopathy mutation E525K in human beta-cardiac myosin stabilizes the interacting-heads motif and super-relaxed state of myosin.人类β-心脏肌球蛋白突变 E525K 稳定肌球蛋白的相互作用头部结构域和超松弛状态。
Elife. 2022 Nov 24;11:e77415. doi: 10.7554/eLife.77415.
5
The biochemically defined super relaxed state of myosin-A paradox.肌球蛋白-A 的生化定义的超级松弛状态悖论。
J Biol Chem. 2024 Jan;300(1):105565. doi: 10.1016/j.jbc.2023.105565. Epub 2023 Dec 14.
6
Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers.从肌球蛋白分子到肌纤维解析人类β-心脏肌球蛋白的超级松弛状态和 mavacamten 的作用模式。
Proc Natl Acad Sci U S A. 2018 Aug 28;115(35):E8143-E8152. doi: 10.1073/pnas.1809540115. Epub 2018 Aug 13.
7
Tail length and E525K dilated cardiomyopathy mutant alter human β-cardiac myosin super-relaxed state.尾部长度和 E525K 扩张型心肌病突变改变人类β-心脏肌球蛋白超松弛状态。
J Gen Physiol. 2024 Jun 3;156(6). doi: 10.1085/jgp.202313522. Epub 2024 May 6.
8
Tail Length and E525K Dilated Cardiomyopathy Mutant Alter Human β-Cardiac Myosin Super-Relaxed State.尾巴长度和E525K扩张型心肌病突变体改变人类β-心脏肌球蛋白超松弛状态。
bioRxiv. 2023 Dec 8:2023.12.07.570656. doi: 10.1101/2023.12.07.570656.
9
Cardiac myosin super relaxation (SRX): a perspective on fundamental biology, human disease and therapeutics.心肌肌球蛋白超松弛(SRX):基础生物学、人类疾病和治疗学的一个视角。
Biol Open. 2021 Feb 15;10(2):bio057646. doi: 10.1242/bio.057646.
10
Variants of the myosin interacting-heads motif.肌球蛋白相互作用头部基序的变体。
J Gen Physiol. 2023 Jan 2;155(1). doi: 10.1085/jgp.202213249. Epub 2022 Nov 8.

引用本文的文献

1
A FRET assay to monitor different structural states of human β-cardiac myosin including the interacting-heads motif.一种用于监测人β-心脏肌球蛋白不同结构状态(包括相互作用头部基序)的荧光共振能量转移(FRET)分析。
Proc Natl Acad Sci U S A. 2025 Aug 26;122(34):e2504562122. doi: 10.1073/pnas.2504562122. Epub 2025 Aug 20.
2
Various challenges in understanding the thick filaments, within and outside skeletal and cardiac muscles.在理解骨骼肌和心肌内外粗肌丝方面存在各种挑战。
Biophys Rev. 2025 Feb 27;17(3):829-834. doi: 10.1007/s12551-025-01289-8. eCollection 2025 Jun.
3
A combined experimental and computational analysis of mantATP turnover in skinned muscle fibers.
对去膜肌纤维中mantATP周转的实验与计算相结合的分析
Proc Natl Acad Sci U S A. 2025 May 20;122(20):e2502652122. doi: 10.1073/pnas.2502652122. Epub 2025 May 15.
4
Mechanistic insights into effects of the cardiac myosin activator omecamtiv mecarbil from mechanokinetic modelling.基于机械动力学模型对心肌肌球蛋白激活剂奥米卡替麦卡比效应的机制性见解
Front Physiol. 2025 Apr 17;16:1576245. doi: 10.3389/fphys.2025.1576245. eCollection 2025.
5
Dynamics of β-cardiac myosin between the super-relaxed and disordered-relaxed states.β-心肌肌球蛋白在超松弛状态和无序松弛状态之间的动力学。
J Biol Chem. 2025 Mar 19;301(5):108412. doi: 10.1016/j.jbc.2025.108412.
6
A FRET assay to quantitate levels of the human β-cardiac myosin interacting heads motif based on its near-atomic resolution structure.一种基于近原子分辨率结构定量人β-心脏肌球蛋白相互作用头部基序水平的荧光共振能量转移分析方法。
bioRxiv. 2024 Dec 10:2024.12.05.626936. doi: 10.1101/2024.12.05.626936.
7
ATP-induced reconfiguration of the micro-viscoelasticity of cardiac and skeletal myosin solutions.三磷酸腺苷(ATP)诱导心脏和骨骼肌肌球蛋白溶液微粘弹性的重新配置。
Appl Phys Lett. 2024 Oct 21;125(17):173702. doi: 10.1063/5.0224003.
8
Interacting myosin head dynamics and their modification by 2'-deoxy-ADP.肌球蛋白头部相互作用及其被 2'-脱氧-ADP 修饰的动力学。
Biophys J. 2024 Nov 19;123(22):3997-4008. doi: 10.1016/j.bpj.2024.10.013. Epub 2024 Oct 22.
9
Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy.重新评估肥厚型心肌病肌球蛋白突变引起的高收缩性的统一假说。
EMBO J. 2024 Oct;43(19):4139-4155. doi: 10.1038/s44318-024-00199-x. Epub 2024 Aug 27.
10
Functional control of myosin motors in the cardiac cycle.心肌收缩周期中肌球蛋白马达的功能控制。
Nat Rev Cardiol. 2025 Jan;22(1):9-19. doi: 10.1038/s41569-024-01063-5. Epub 2024 Jul 19.